1Bonnefont, J-P, Djouadi, F, Prip-Buus, C, et al. (2004) Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 25, 495–520.
2Robitaille, J, Houde, A, Lemieux, S, et al. (2007) Variants within the muscle and liver isoforms of the carnitine palmitoyltransferase I (CPT1) gene interact with fat intake to modulate indices of obesity in French-Canadians. J Mol Med 85, 129–137.
3Miljkovic, I, Yerges, LM, Li, H, et al. (2009) Association of the CPT1B gene with skeletal muscle fat infiltration in Afro-Caribbean men. Obesity 17, 1396–1401.
4Levy, D, Garrison, RJ, Savage, DD, et al. (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322, 1561–1566.
5Alberti, KG, Zimmet, P & Shaw, J (2006) Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23, 469–480.
6Rubin, D, Helwig, U, Nothnagel, M, et al. (2010) Association of postprandial and fasting triglycerides with traits of the metabolic syndrome in the Metabolic Intervention Cohort Kiel (MICK). Eur J Endocrinol 162, 719–727.
7Matthews, DR, Hosker, JP, Rudenski, AS, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
8Mari, A, Pacini, G, Murphy, E, et al. (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24, 539–548.
9Bedogni, G, Bellentani, S, Miglioli, L, et al. (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6, 33–39.
10Hampe, J, Shaw, SH, Saiz, R, et al. (1999) Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 65, 1647–1655.
11Barrett, JC, Fry, B, Maller, J, et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265.
12Li, SS, Khalid, N, Carlson, C, et al. (2003) Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics 4, 513–522.
13Tanaka, T, Yamamoto, J, Iwasaki, S, et al. (2003) Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100, 15924–15929.
14Vedala, A, Wang, W, Neese, RA, et al. (2006) Delayed secretory pathway contributions to VLDL–triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans. J Lipid Res 47, 2562–2574.
15Dobbins, RL, Szczepaniak, LS, Bentley, B, et al. (2001) Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 50, 123–130.
16Bruce, CR, Hoy, AJ, Turner, N, et al. (2009) Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 58, 550–558.
17Perdomo, G, Commerford, SR, Richard, AM, et al. (2004) Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J Biol Chem 279, 27177–27186.
18Kim, JK, Michael, MD, Previs, SF, et al. (2000) Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 105, 1791–1806.
19Petersen, KF, Dufour, S, Savage, DB, et al. (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A 104, 12587–12594.
20Yamazaki, N, Matsuo, T, Kurata, M, et al. (2008) Substitutions of three amino acids in human heart/muscle type carnitine palmitoyltransferase I caused by single nucleotide polymorphisms. Biochem Genet 46, 54–63.
21Kraja, AT (2010) Metabolic syndrome – modern pharmacological, genetic, clinical and environmental contributions. Endocr Metab Immune Disord Drug Targets 10, 84–85.
22Zabaneh, D & Balding, DJ (2010) A genome-wide association study of the metabolic syndrome in Indian Asian men. PLoS One 5, e11961.
23Pearson, TA & Manolio, TA (2008) How to interpret a genome-wide association study? JAMA 299, 1335–1344.